Comprehensive insights into oral squamous cell carcinoma: Diagnosis, pathogenesis, and therapeutic advances
Pathology - Research and Practice · 2024-09 · 261 · 155489
DOI: 10.1016/j.prp.2024.155489 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024-09. Verfasst von Dharshini Jagadeesan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Faculty of Applied Sciences, AIMST University, Bedong, Kedah, Malaysia. Hauptthemen laut MEDLINE: Mouth Neoplasms. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 279 Literaturangaben.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is considered the most common type of head and neck squamous cell carcinoma (HNSCC) as it holds 90 % of HNSCC cases that arise from multiple locations in the oral cavity. The last three decades witnessed little progress in the diagnosis and treatment of OSCC the aggressive tumor. However, in-depth knowledge about OSCC's pathogenesis, staging & grading, hallmarks, and causative factors is a prime requirement in advanced diagnosis and treatment for OSCC patients. Therefore present review was intended to comprehend the OSCCs' prevalence, staging & grading, molecular pathogenesis including premalignant stages, various hallmarks, etiology, diagnostic methods, treatment (including FDA-approved drugs with the mechanism of action and side effects), and theranostic agents. The current review updates that for a better understanding of OSCC progress tumor-promoting inflammation, sustained proliferative signaling, and growth-suppressive signals/apoptosis capacity evasion are the three most important hallmarks to be considered. This review suggests that among all the etiology factors the consumption of tobacco is the major contributor to the high incidence rate of OSCC. In OSCC diagnosis biopsy is considered the gold standard, however, toluidine blue staining is the easiest and non-invasive method with high accuracy. Although there are various therapeutic agents available for cancer treatment, however, a few only are approved by the FDA specifically for OSCC treatment. The present review recommends that among all available OSCC treatments, the antibody-based CAR-NK is a promising therapeutic approach for future cancer treatment. Presently review also suggests that theranostics have boosted the advancement of cancer diagnosis and treatment, however, additional work is required to refine the role of theranostics in combination with different modalities in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Faculty of Applied Sciences, AIMST University, Bedong, Kedah, Malaysia.
- Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia. Electronic address: neerajkumar@aimst.edu.my.
- Institute for Research in Molecular Medicine, Universiti Sains Malaysia,11800 USM, Pulau Pinang, Malaysia.
- Centre of Preclinical Science Studies, Faculty of Dentistry, Universiti Teknologi MARA, Sungai Buloh Campus, Jalan Hospital, SungaiBuloh, Selangor 47000, Malaysia; Oral and Maxillofacial Cancer Research Group, Faculty o…
- Faculty of Pharmacy, AIMST University, Bedong, Kedah, Malaysia. Electronic address: shivkanya_fuloria@aimst.edu.my.
- Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Punjab, India; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Zitieren
APA
Jagadeesan, D., Sathasivam, K. V., Fuloria, N. K., Balakrishnan, V., Khor, G. H., Ravichandran, M., Solyappan, M., Fuloria, S., Gupta, G., Ahlawat, A., Yadav, G., Kaur, P., & Husseen, B. (2024). Comprehensive insights into oral squamous cell carcinoma: Diagnosis, pathogenesis, and therapeutic advances. Pathology - Research and Practice, 261, 155489. https://doi.org/10.1016/j.prp.2024.155489
Vancouver
Jagadeesan D, Sathasivam KV, Fuloria NK, Balakrishnan V, Khor GH, Ravichandran M, et al. Comprehensive insights into oral squamous cell carcinoma: Diagnosis, pathogenesis, and therapeutic advances. Pathology - Research and Practice. 2024;261:155489. doi:10.1016/j.prp.2024.155489
BibTeX
@article{Jagadeesan2024,
author = {Jagadeesan, Dharshini and Sathasivam, Kathiresan V and Fuloria, Neeraj Kumar and Balakrishnan, Venugopal and Khor, Goot Heah and Ravichandran, Manickam and Solyappan, Maheswaran and Fuloria, Shivkanya and Gupta, Gaurav and Ahlawat, Abhilasha and Yadav, Geeta and Kaur, Pandeep and Husseen, Beneen},
title = {Comprehensive insights into oral squamous cell carcinoma: Diagnosis, pathogenesis, and therapeutic advances},
journal = {Pathology - Research and Practice},
year = {2024},
volume = {261},
pages = {155489},
doi = {10.1016/j.prp.2024.155489}
}
EUVIMED